Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?

Hasan Çilgin Medicine Faculty, Obstetrics and Gynecology Department, Kafkas University, Kars, Turkey Purpose: This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline.Materials and method...

Full description

Bibliographic Details
Main Author: Çilgin H
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/can-a-cyclooxygenase-inhibitor-be-an-option-for-treatment-of-ovarian-h-peer-reviewed-article-DDDT